Draft genomes of non-nitrogen-fixing Frankia strains.
- Carlos-Shanley C, Guerra T and Hahn D (2021).
- J Genomics.
- DOI:
- 10.7150/jgen.65429
- PubMed:
- 34703504
Two critically ill COVID-19 patients were treated with a Hemopurifier, which removes mannosylated viruses and exosomes released by activated cells. Both patients tolerated the treatment well. In one patient, removal of exosomes was associated with improved coagulopathy, oxygenation, and clinical recovery. In the second patient, removal of COVID-19 by the Hemopurifier was observed. The Hemopurifier is currently being further investigated in a safety and feasibility study with up to 40 patients in ICU with COVID-19 infection.